Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2005
10/20/2005WO2005097980A2 New protocols for making hepatocytes from embryonic stem cells
10/20/2005WO2005097979A2 Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof
10/20/2005WO2005097978A1 Modulation of granulosa cell proliferation and differentiation
10/20/2005WO2005097977A2 Differentiation of stem cells to endoderm and pancreatic lineage
10/20/2005WO2005097976A1 Dendritic cell obtained by antigen pulsing
10/20/2005WO2005097975A1 Method for the production of a biological material composition having an animal origin
10/20/2005WO2005097974A2 Method for the production of a cell composition containing epithelial cells
10/20/2005WO2005097832A2 Humanized anti-tgf-beta antibodies
10/20/2005WO2005097190A2 Systems and methods for providing a stem cell bank
10/20/2005WO2005097156A1 Remedy for neurodegenerative diseases
10/20/2005WO2005097154A2 Neurotransmitter mixture which promotes the healing of wounds
10/20/2005WO2005097147A1 Restenosis therapy using mesenchymal stem cells
10/20/2005WO2005096706A2 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
10/20/2005WO2005030040A8 Hematopoietic stem cell identification and isolation
10/20/2005WO2004083384A3 Accelerated culture system for intestinal epithelial cell monolayers
10/20/2005WO2004064785A3 Cancer therapy sensitizer
10/20/2005WO2003074668A3 Models of cellular development using homozygous stem cells
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050235380 Acquired resistance genes in plants
10/20/2005US20050235378 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
10/20/2005US20050235375 Transcription factors of cereals
10/20/2005US20050235371 Noval modified MSP-1 nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
10/20/2005US20050235368 Method of transporting transgenic Xenopus laeves oocytes
10/20/2005US20050235367 Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof
10/20/2005US20050235366 A transgenic mouse whose genome comprises a transgene encoding metabotropic glutamate receptor 1 (Grm1) operably linked to the melanocyte-specific promoter expresses the Grm 1 in melanocytes, develops lesions on hairless skin, and lacks pigmentation; screening anticarcinogenic agents; medical diagonosis
10/20/2005US20050235365 Helicokinin-receptor from insects
10/20/2005US20050234513 Implantable neuronal networks
10/20/2005US20050234226 Persephin and related growth factors
10/20/2005US20050234225 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050234003 Method of using nucleic acid compositions for muting expression of a gene in animals
10/20/2005US20050234001 Methods and compositions for modulating gluconeogenesis using PGC-1
10/20/2005US20050233992 Regeneration of endogeneous myocardial tissue by induction of neovascularization
10/20/2005US20050233989 Flavin N-oxides: new anti-cancer agents and pathogen eradication agents
10/20/2005US20050233956 Proteins involved in the regulation of energy homeostasis
10/20/2005US20050233955 Stimulation of nerve cell regeneration
10/20/2005US20050233453 6-O-sulfated N-acetylheparosan and hematopoietic stem cell growth auxiliary agent
10/20/2005US20050233452 Cell populations which co-express CD49c and CD90
10/20/2005US20050233451 Stimulating peripheral blood mononuclear cells in vitro with antigen, transducing with retroviral vector and reintroducing into patient
10/20/2005US20050233450 Methods of inducing hair growth
10/20/2005US20050233449 Simple and rapid derivation of functional hepatocytes from human bone marrow-derived mesenchymal stem cells
10/20/2005US20050233448 Apparatus comprising gas permeable membrane/scaffolds for use in cell propagation and enhancing progenitor cell recovery; bioreactors
10/20/2005US20050233447 A cell simultaneously expressing albumin protein and a membrane-associated CD14 surface antigen; expresses a mRNA sequence typical of hepatocytes selected from the group consisting of alpha-fetoprotein, carbamyl phosphate synthetase I, coagulation factor II, and coagulation factor VII
10/20/2005US20050233446 Defined media for stem cell culture
10/20/2005US20050233445 Biomimetic urothelium
10/20/2005US20050233444 System and method for forming a non-ablative cardiac conduction block
10/20/2005US20050233443 Restenosis therapy using mesenchymal stem cells
10/20/2005US20050233442 Carrier for cell culture
10/20/2005US20050233441 Liquid injection conduit, the surface of the liquid in free contact with the air, a collector element forming a meniscus with the free surface of the liquid regulating surface tension, a mouthpiece to absorb a flow of air
10/20/2005US20050233417 Growth hormone variations in humans and their uses
10/20/2005US20050233416 Mutant protein with insertion, deletion, or replacement; lysine production; gene expression
10/20/2005US20050233415 From mammal cells transformed with cytomegalovirus vector using xanthine derivatives (caffeine and/or theobromine) and/or hexamethylene bisacetamide; serum-free
10/20/2005US20050233408 Modified bacterial surface layer proteins
10/20/2005US20050233403 Human adipocyte cell populations and methods for identifying modulators of same
10/20/2005US20050233386 Human hematopoietic growth regulatory gene and uses
10/20/2005US20050233385 Using antibodies on cell surfaces
10/20/2005US20050233374 Reagents and methods useful for detecting diseases of the prostate
10/20/2005US20050233371 CNG2B: a novel human cyclic nucleotide-gated ion channel
10/20/2005US20050233362 Method for collecting purified cells
10/20/2005US20050233359 Isolated nucleic acid molecule encoding a neurotrophic growth factor
10/20/2005US20050233355 Human cDNAs encoding polypeptides having kinase functions
10/20/2005US20050233348 Using recombinant protein binding domains as tools for monitoring ligand binding activity in cells
10/20/2005US20050233328 Methods of identifying compounds that modulate protein activity
10/20/2005US20050233301 Cryopreservation of haptenized tumor cells
10/20/2005US20050232950 Viruses comprising mutant ion channel protein
10/20/2005US20050232941 Compounds and methods for treatment and diagnosis of chlamydial infection
10/20/2005US20050232938 Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/20/2005US20050232937 Paramycobacterial diagnostics and vaccines
10/20/2005US20050232932 Compositions and methods for dendritic cell-based immunotherapy
10/20/2005US20050232926 Expressed in melanoma, breast cancer and hepatocellular carcinoma; fab fragments; fv fragments; competitive binding; for inducing caspase mediated apoptosis; neoplasm diagnosis
10/20/2005US20050232922 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
10/20/2005US20050232919 Monoclonal antibodies that specifically block biological activity of a tumor antigen
10/20/2005US20050232917 Antibodies to MAdCAM
10/20/2005US20050232906 Adjuvant preparation for the induction of specific immunity
10/20/2005US20050232905 Use of peripheral blood cells for cardiac regeneration
10/20/2005US20050232904 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
10/20/2005US20050232903 Mincing tissue, culturing with growth factors, bone morphogenetic protein or vitamin D; propagating in alginate, agarose and collagen to form 3-dimensional structure
10/20/2005US20050232902 Injectable bioartificial tissue matrix
10/20/2005US20050232900 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination
10/20/2005CA2563887A1 Mite allergen zen 1
10/20/2005CA2563513A1 Remedy for neurodegenerative diseases
10/20/2005CA2561686A1 Humanized anti-tgf-beta antibodies
10/20/2005CA2561276A1 Irta-5 antibodies and their uses
10/20/2005CA2560725A1 Systems and methods for providing a stem cell bank
10/20/2005CA2560655A1 Method for improving plants
10/20/2005CA2560334A1 Non-invasive, in vitro functional tissue assay systems
10/19/2005EP1586658A2 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal
10/19/2005EP1586653A1 Noc2 knockout mouse
10/19/2005EP1586650A1 Intervention in the energy metabolism of eukaryotic cells for selection and increase of expression
10/19/2005EP1586649A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
10/19/2005EP1586646A2 Lawsonia intracellularis vaccine
10/19/2005EP1586641A2 Compounds for the treatment of hypercalcemia and hypocalcemia
10/19/2005EP1586638A1 Monoclonal antibody for immunologically analyzing or concentrating endocrine disruptor or its degradation product and utilization of the same
10/19/2005EP1586637A1 Novel nitrile hydratase
10/19/2005EP1586636A1 Hydantoinase variants with improved properties and their use for the production of amino acids
10/19/2005EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use
10/19/2005EP1586634A1 Method of producing infectious reovirus
10/19/2005EP1586633A1 Method for preparing totipotent porcine cells
10/19/2005EP1586326A1 Pharmaceutical compositions for treating neuronal damage and neurodegenerative diseases
1 ... 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 ... 1827